The artificial cornea is 100% made of non-biological materials and require no co-implantation of donor corneas and it is an ideal option for treating patients with corneal blindness
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
The stability is led by healthy demand in the domestic and emerging markets
This surpasses the number of approvals supported in 2020
Under the terms of the agreement, Arrakis will lead research activities for the identification of RNA-targeted small molecule (rSM) binders against a broad set of targets nominated by Amgen
The product will be marketed under store brand labels and is comparable to the brand Zyrtec
In addition to its favourable activity profile, IBIO123 is formulated for administration by inhalation providing an efficient, rapid and non-invasive delivery method into the lungs via the respiratory tract
The brand is now available pan-India through their distribution partner
It is the generic version of molnupiravir
The latest research results indicated that JMB2002 had high binding activity to the Omicron variant and showed potent Omicron pseudovirus neutralization function
Subscribe To Our Newsletter & Stay Updated
